Negli ultimi tre anni il CuLCaSG ha prodotto i seguenti studi clinici:

Attenzione: gli articoli, come originariamente scritti, sono in inglese.   Pertanto, sono contenuti nella versione inglese di questo sito.  Per tornare a navigare nella parte italiana bisogna usare il tasto di navigazione del proprio browser.

SERUM BIOMARKERS FACILITATE THE RECOGNITION OF EARLY STAGE CANCER AND MAY GUIDE THE SELECTION OF SURGICAL CANDIDATES (Gianfranco Buccheri et al.)	Pubblicato in The Journal of Thoracic and Cardiovascular Surgery 2001; 122: 891-899
IMPORTANCE OF WEIGHT LOSS DEFINITION IN THE PROGNOSTIC EVALUATION OF NON-SMALL CELL LUNG CANCER (Gianfranco Buccheri et al.)	Pubblicato in  Lung Cancer 2001; 34: 433-440
PROGNOSTIC SIGNIFICANCE OF BLOOD COAGULATION TESTS IN LUNG CANCER (Domenico Ferrigno et al.)	Pubblicato in  Eur.Resp.J. 2001; 17:667-673
OVERVIEW ON SERUM TUMOR MARKERS OF CYTOKERATIN ORIGIN (Gianfranco Buccheri)	Pubblicato in Expert Rev. Mol Diagn. 2001, 1 (3), 89-96
NUTRITIONAL STATUS ASSESSMENT OF PATIENTS WITH LUNG CANCER (Domenico Ferrigno et al.)	Pubblicato in Support Care Cancer 2001; 9, 522-527
99mTc-TETROFOSMIN SCIENTIGRAPHY IN LUNG CANCER STAGING AND FOLLOW-UP EVALUATIONS (Gianfranco Buccheri et al.)	Pubblicato in Cancer 2002; 94:1796-1807
LUNG TUMOUR MARKERS TPA AND CA125: A COMPARISON STUDY (Gianfranco Buccheri et al.)	Pubblicato in Br J Cancer 2002; 87:1112-1118
PREOPERATIVE MEASUREMENTS OF CARCINOEMBRYONIC ANTIGEN MAY PREDICT EARLY RECURRENCE IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER (Gianfranco Buccheri et al.)	Pubblicato in Annals of Thoracic Surgery 2003; 75:973-980
CLINICAL EQUIVALENCE OF TWO CYTOKERATIN MARKERS IN LUNG CANCER: a study of TPA and Cyfra 21-1 (Gianfranco Buccheri et al.)	Pubblicato in CHEST  2003; 124:622-632
D-DIMER PLASMA LEVELS IN LUNG CANCER: CLINICAL AND PROGNOSTIC SIGNIFICANCE (Gianfranco Buccheri et al.)	Pubblicato in Cancer 2003; 97:3044-3052
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC) (Domenico Ferrigno et al.)	Pubblicato in Lung Cancer 2003; 41:311-320
Lung cancer in North-West Italy: demographic and clinical trends in a hospital-based population of 1277 patients (Gianfranco Buccheri et al.)	Pubblicato in Eur J Cancer Prevention 2003 Dec;12(6):455-61
Familial and personal history of cancer in bronchogenic carcinoma--frequency and clinical implications (Gianfranco Buccheri et al.)	Pubblicato in Acta Oncol. 2004;43(1):65-72
Prognostic factors in NSCLC (Gianfranco Buccheri et al.)	Pubblicato in Hematol Oncol Clin North Am. 2004 Feb;18(1):187-201
Prognostic factors of small cell lung cancer (Gianfranco Buccheri et al.)	Pubblicato in Hematol Oncol Clin North Am. 2004 Apr;18(2):445-60
Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients (Domenico Ferrigno et al.)	Pubblicato in Monaldi Arch Chest Dis. 2003 Jul-Sep;59(3):193-8
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients (Jean-Louis Pujol et al.)	Pubblicato in Br J Cancer. 2004 Jun 1;90(11):2097-105
Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin (Gianfranco Buccheri et al.)	Pubblicato in Lung Cancer. 2004 Aug;45(2):227-36
Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC) (Domenico Ferrigno et al.)	Pubblicato in Lung Cancer. 2004 Sep;45(3):373-80
Lung cancer: clinical presentation and specialist referral time (Gianfranco Buccheri et al.)	Pubblicato in Eur Respir J. 2004 Dec;24(6):898-904